Ana Gómez‐Rueda

Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping

J. Zugazagoitia, Inmaculada Ramos, José Trigo et al. · Annals of Oncology · 2018 · 83 citations · Full text

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti–PD-1 for patients with anti–PD-1–refractory tumors

Iván Márquez‐Rodas, Federico Longo, María E. Rodríguez-Ruiz et al. · Science Translational Medicine · 2020 · 80 citations

Canakinumab with and Without Pembrolizumab in Patients with Resectable Non-Small-Cell Lung Cancer: CANOPY-N Study Design

Pilar Garrido, Jean-Louis Pujol, Edward S. Kim et al. · Future Oncology · 2021 · 46 citations

Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance

Jon Zugazagoitia, Ana Gómez‐Rueda, Eloísa Jantus‐Lewintre et al. · Lung Cancer · 2019 · 25 citations

Oncology, Sequencing, Tumor Heterogeneity +9

Sarcoidosis-like reactions in cancer patients treated with immune checkpoint inhibitors: experience in a Spanish hospital

Javier Torres-Jiménez, Jorge Esteban-Villarrubia, P. García‐Abellás et al. · Clinical & Translational Oncology · 2021 · 12 citations

Spanish Hospital, Medicine, Immunology +8